|Articles|December 1, 2016
- BioPharm International-12-01-2016
- Volume 29
- Issue 12
BioPharm International, December 2016 Issue (PDF)
Click the title above to open the BioPharm International December 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Cross Contamination in Biopharmaabout 9 years ago
Expression systems for the development of biosimilarsabout 9 years ago
Large-Scale Protein Expression in Baculovirus-Infected Insect Cellsabout 9 years ago
Automated Microscope for Multimodal Imagingabout 9 years ago
Chromatograph Enables Fast Recovery of Target Compoundsabout 9 years ago
A Coiled Flow Inversion Reactor Enables Continuous Processingabout 9 years ago
Nurturing the Relationship Between Industry and Regulatorsabout 9 years ago
Stimulating Biosimilar Uptake: Implications for Manufacturersabout 9 years ago
Pharmaceutical Manufacturers Gear Up for Political ChangeNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
FAQ: Shifts in FDA Regulations and Strategies in 2025
4
Charles River Incubator Cohort to Accelerate CGT Development
5
